newsfilter
← Latest News
ClinicalTrials.gov·

Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes - NCT05670379

Area under the plasma concentration-time curve (AUC), Maximum plasma concentration observed (Cmax), Time to maximum plasma concentration observed (Tmax), (and 3 more...)